In which clinical situations are beta‑blockers contraindicated for patients with arrhythmia?

Beta-Blocker Contraindications in Arrhythmia

Beta-blockers are contraindicated in arrhythmia patients with pre-excited atrial fibrillation (Wolff-Parkinson-White syndrome), severe bronchospasm, hemodynamic instability, decompensated heart failure, significant bradycardia, high-degree AV block without a pacemaker, and cardiogenic shock. 1, 2

Absolute Contraindications

Pre-Excited Atrial Fibrillation (WPW Syndrome)

• Beta-blockers are potentially harmful in patients with Wolff-Parkinson-White syndrome and pre-excited AF because they can accelerate ventricular rate by blocking the AV node and forcing conduction through the accessory pathway 1, 2
• This is a Class III: Harm recommendation—meaning beta-blockers should never be used in this scenario
• Instead, use direct-current cardioversion if hemodynamically unstable, or intravenous procainamide/ibutilide if stable 2

Severe Bronchospasm and Active Asthma

• Non-selective beta-blockers, sotalol, propafenone, and adenosine are contraindicated in patients with bronchospasm 1, 3
• This includes patients with severe reactive airway disease and active asthma 4
• Important caveat: Stable chronic obstructive pulmonary disease (COPD) is NOT an absolute contraindication 5
• In COPD patients requiring rate control, use non-dihydropyridine calcium channel blockers (diltiazem or verapamil) as first-line 1, 2, 3
• If beta-blockers are necessary in stable COPD, use beta-1 selective agents (bisoprolol or metoprolol) at low doses after correcting hypoxia 1, 3

Hemodynamic Instability and Cardiogenic Shock

• Do not use beta-blockers in patients with:
  • Signs of heart failure (rales, S3 gallop) 6, 7, 8
  • Evidence of low-output state (oliguria) 7, 8
  • Hypotension (systolic BP <90 mmHg) 7, 8
  • Increased risk for cardiogenic shock 6
  • Acute decompensated heart failure 4

Risk factors for cardiogenic shock include: age >70 years, systolic BP <120 mmHg, sinus tachycardia >110 bpm or heart rate <60 bpm, and increased time since symptom onset 6

Conduction Abnormalities

• Contraindicated in:
  • Marked first-degree AV block (PR interval >0.24 seconds) 6, 7, 8
  • Second- or third-degree AV block without a functioning pacemaker 6, 7, 8
  • Severe sinus node dysfunction 4
  • Significant sinus bradycardia (heart rate <50 bpm) 7, 8

Context-Specific Contraindications

Acute Coronary Syndromes

Beta-blockers should NOT be given intravenously to ACS patients with 2:

• Heart failure
• Hemodynamic instability
• Bronchospasm
• Signs of low output state

However, oral beta-blockers are recommended within 24 hours for stable ACS patients without these contraindications 2

Multifocal Atrial Tachycardia

• Beta-blockers are typically avoided in severe underlying pulmonary disease, particularly with bronchospasm 4
• However, metoprolol has been used successfully in small studies after correction of hypoxia 4

Clinical Algorithm for Decision-Making

Before prescribing beta-blockers for arrhythmia, systematically assess:

1. Check for accessory pathway: If pre-excited AF or WPW → NEVER use beta-blockers
2. Assess hemodynamics: If hypotensive, signs of shock, or decompensated HF → AVOID
3. Evaluate respiratory status: If active bronchospasm or severe asthma → AVOID; if stable COPD → consider beta-1 selective agents
4. Review ECG: If PR >0.24s, second/third-degree block, or severe bradycardia → AVOID unless pacemaker present
5. Consider clinical context: If acute MI with high shock risk → delay until stabilized

Common Pitfalls

• Don't confuse stable COPD with active bronchospasm: Stable COPD is not an absolute contraindication if beta-1 selective agents are used cautiously 5, 3
• Don't use beta-blockers for rate control in WPW with AF: This accelerates ventricular rate and can be fatal 1, 2
• Don't give IV beta-blockers in acute MI without assessing shock risk: The COMMIT trial showed increased cardiogenic shock risk in patients with tachycardia or Killip Class II-III 7, 8
• Don't combine verapamil with beta-blockers acutely: Risk of profound bradycardia and hypotension 9

When beta-blockers are contraindicated for rate control in AF, use non-dihydropyridine calcium channel blockers (diltiazem or verapamil) as the preferred alternative 1, 2, 3, except in WPW where these are also contraindicated 2.